Abbott Laboratories (NYSE:ABT) is included among the Dividend Growth Stocks: 25 Aristocrats. A Reuters report said Abbott ...

Abbott Laboratories has a great financial position. The long-term debt/equity ratio is 0.3, while the interest coverage ratio ...

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...

In recent weeks, Abbott Laboratories raised its quarterly dividend for the 52nd consecutive year and secured CE Mark approval ...

The stock is near its 52-week low.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories (NYSE: ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT ...

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two stocks offers value investors a ...